Generics - Teva Pharmaceutical Industries

Filter

Popular Filters

100 to 124 of 1309 results

Amneal appoints former Warner Chilcott senior VP Rochelle Fuhrmann as CFO

14-01-2014

Privately-held US generics drugmaker Amneal has announced Rochelle Fuhrmann has joined the company as…

Amneal PharmaBoardroomGenericsUSAWarner Chilcott

2014: A new dawn for pharma?

2014: A new dawn for pharma?

10-01-2014

We take a look at the week's top stories.

Asia-PacificManagementNovartisPharmaceuticalTeva Pharmaceutical IndustriesUK

J&J’s Janssen units file Citizen Petition with FDA on biosimilars naming

J&J’s Janssen units file Citizen Petition with FDA on biosimilars naming

09-01-2014

Health care giant Johnson & Johnson’s Janssen Pharmaceutical companies have submitted a Citizen Petition…

BiosimilarsGenericsJanssenJohnson & JohnsonNorth AmericaRegulationUSA

NuPathe receives counter offer from Teva topping Endo bid

09-01-2014

US drugmaker NuPathe – currently the subject of a takeover bid from USA-based Endo Health Solutions…

Endo Health SolutionsMergers & AcquisitionsNuPathePharmaceuticalTeva Pharmaceutical Industries

Teva confirms appointment of Erez Vigodman as president and CEO

Teva confirms appointment of Erez Vigodman as president and CEO

09-01-2014

Somewhat sooner than expected, Isael’s Teva Pharmaceutical Industries, the world’s largest generics…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Ranbaxy cleared to market branded generic of Aricept in Canada

Ranbaxy cleared to market branded generic of Aricept in Canada

08-01-2014

The Canadian subsidiary of Ranbaxy Laboratories has received approval to manufacture and market RAN-Donepezil…

AriceptCanadaDaiichi SankyoEisaiGenericsNeurologicalNorth AmericaRAN-DonepezilRanbaxy LaboratoriesRegulation

US national health spending growth remains low for 4th consecutive year

07-01-2014

Overall national health expenditures in the USA grew at an annual rate of 3.7% in 2012, marking the fourth…

FinancialGenericsHealthcareNorth AmericaPharmaceuticalUSA

Teva looks set to name Erez Vigodman as new CEO

Teva looks set to name Erez Vigodman as new CEO

07-01-2014

Speculation is mounting that Israel’s Teva Pharmaceutical Industries is about to appoint a new chief…

BoardroomGenericsManagementPharmaceuticalTeva Pharmaceutical Industries

Amneal debuts generic Esomeprazole strontium in USA

07-01-2014

Privately-held US generics drugmaker Amneal Pharmaceuticals has announced the launch of generic esomeprazole…

Amneal PharmaAstraZenecaEsomeprazole MagnesiumGastro-intestinalsGenericsMarkets & MarketingNexiumNorth AmericaUSA

Teva launches authorized generic of Detrol in USA

Teva launches authorized generic of Detrol in USA

04-01-2014

Israel’s Teva Pharmaceutical Industries, the world’s largest generic drugmaker, says it has launched…

Detrol LAGenericsGenito-urinaryMarkets & MarketingNorth AmericaPfizerTeva Pharmaceutical IndustriesUSA

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

Mylan hires Rakesh Bamzai as president, India commercial and emerging markets

04-01-2014

US drugmaker Mylan says that Rakesh Bamzai has joined the company and has been appointed president, India…

BoardroomGenericsManagementMylan Laboratories

US FTC rescheduled workshop on state regulations and naming conventions set for February

31-12-2013

The US Federal Trade Commission announced its one-day public workshop on competition and follow-on biologics,…

BiosimilarsGenericsMarkets & MarketingNorth AmericaRegulationUSA

Nissan Chemical and Kowa to sue generic drugmakers over Livalo patent infringements

30-12-2013

With the commencement this year of manufacturing and selling generic copies of the hypercholesterolemia…

Asia-PacificCardio-vascularGenericsKowaLegalLivaloNissan ChemicalPatents

US Office of Generic Drugs reorganization

US Office of Generic Drugs reorganization

29-12-2013

The US Food and Drug Administration’s Center for Drug Evaluation and Research has approved plans to…

GenericsNorth AmericaRegulationUSA

Hepalink to acquire USA’s Scientific Protein Laboratories

27-12-2013

China’s Shenzhen Hepalink Pharmaceutical has entered into a stock purchase agreement to acquire USA-based…

GenericsheparinMergers & AcquisitionsScientific Protein LaboratoriesShenzhen Hepalink Pharmaceutical

ANI Pharma buys 31 generic drugs from Teva

ANI Pharma buys 31 generic drugs from Teva

27-12-2013

Emerging US generic drugmaker ANI Pharmaceuticals says that it has acquired 31 previously marketed generic…

ANI PharmaceuticalsGenericsMergers & AcquisitionsTeva Pharmaceutical Industries

Sandoz to commercialize Taiwan Liposome’s antifungal

Sandoz to commercialize Taiwan Liposome’s antifungal

19-12-2013

Taipei-based biopharmaceutical company Taiwan Liposome Company has entered into a collaboration agreement…

Amphotericin BAntibiotics and Infectious diseasesAsia-PacificGenericsLicensingNovartisSandozTaiwan Liposome

Mixed US court decision on ViiV Healthcare’s Epzicom and Trizivir patents

19-12-2013

UK pharma giant GlaxoSmithKline and ViiV Healthcare confirmed that the US District Court for the District…

Anti-viralsEpzicomGenericsGlaxoSmithKlineLegalLupinPatentsTeva Pharmaceutical IndustriesTrizivirViiV Healthcare

Rapid uptake of rheumatoid arthritis biosimilars expected in Brazil and Mexico

19-12-2013

Biosimilars will be quickly acquired and used in public health institutions in the treatment of patients…

Anti-Arthritics/RheumaticsBiosimilarsBrazilGenericsMarkets & MarketingRegulationSouth America

Joint generic drug inspections initiative announced by FDA and EMA

Joint generic drug inspections initiative announced by FDA and EMA

19-12-2013

In a joint statement, the US Food and Drug Administration and the European Medicines Agency revealed…

EuropeGenericsNorth AmericaProductionRegulation

Brazil’s ANVISA and ProGenericos sign cooperation agreement

Brazil’s ANVISA and ProGenericos sign cooperation agreement

18-12-2013

Brazil's National Health Surveillance Agency, ANVISA has signed a memorandum of technical and operational…

BiosimilarsBrazilGenericsRegulationResearchSouth America

Patent settlements for Pfizer/Teva and Mylan/Eisai

Patent settlements for Pfizer/Teva and Mylan/Eisai

18-12-2013

US pharma behemoth Pfizer says it has settled its long-standing litigation against a US subsidiary of…

Banner PharmacapsEisaiGenericsLegalMen's HealthMylan LaboratoriesNorth AmericaOncologyPatentsPfizerTargretinTeva Pharmaceutical IndustriesValeant PharmaceuticalsViagra

100 to 124 of 1309 results

Back to top